Clinical Trials Browser

Phase 4 × Completed × Melanoma × Clear all

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Melanoma

NCT01794793 2024-10-01

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

Acromegaly, Dumping Syndrome, Melanoma, Neoplasms, Pituitary Neoplasms, Prostatic Neoplasms, Neuroendocrine Tumors, Pituitary ACTH Hypersecretion

NCT04074460 2022-06-09

VAPOR-C

Phase 4 Completed

169 enrolled

BreastDermatologicGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Prostatic Neoplasms

NCT00414765 2021-06-08

Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Phase 4 Completed

26 enrolled 7 charts

DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma

NCT02451488 2020-02-10

Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Cutaneous Stage L-lll Melanoma

Phase 4 Completed

8 enrolled 5 charts

Dermatologic

Melanoma

NCT01898585 2020-01-07

An Open-Label Study of Zelboraf (Vemurafenib) in Patients With Braf V600 Mutation Positive Metastatic Melanoma

Phase 4 Completed

60 enrolled

Dermatologic

Melanoma

NCT01053819 2018-02-23

Can We Miss Pigmented Lesions in Psoriasis Patients?

Phase 4 Completed

6 enrolled 3 charts

Dermatologic

Melanoma, Psoriasis

NCT00324272 2011-08-11

Post-Operative Drainage Following Lymph Node Dissection

Phase 4 Completed

74 enrolled 16 charts

Dermatologic

Carcinoma, Squamous Cell, Melanoma, Seroma

NCT00075166 2008-03-04

Surgery Versus Radiosurgery to Treat Metastatic Brain Tumors

Phase 4 Completed

130 enrolled

CNSDermatologic

Brain Neoplasms, Carcinoma, Melanoma, Neoplasm Metastasis

Clinical Trials

Keynote-593

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

VAPOR-C

Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Cutaneous Stage L-lll Melanoma

An Open-Label Study of Zelboraf (Vemurafenib) in Patients With Braf V600 Mutation Positive Metastatic Melanoma

Can We Miss Pigmented Lesions in Psoriasis Patients?

Post-Operative Drainage Following Lymph Node Dissection

Surgery Versus Radiosurgery to Treat Metastatic Brain Tumors